DFMO and celecoxib in combination for cancer chemoprevention and therapy

Year	Description
2000	Invention patented by Richard Love on May 16th, 2000. Abstract: Celecoxib, a COX-2 specific non-steroidal anti-inflammatory agent, is provided in combination with DFMO for the prevention and/or treatment of cancers. Provided with the present invention are pharmaceutically acceptable compositions that include a non-steroidal anti-inflammatory agent, celecoxib, together with an effective amount of difluoromethylornithine.
Source: selected by the editor from original sources.

Invention: DFMO and celecoxib in combination for cancer chemoprevention and therapy